1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for GUTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2025. Start Trial.
Date Value
September 18, 2026 -39.27%
September 17, 2026 -39.24%
September 16, 2026 -43.46%
September 15, 2026 -42.46%
September 14, 2026 -40.04%
September 11, 2026 -37.25%
September 10, 2026 -35.04%
September 09, 2026 -34.18%
September 08, 2026 -26.28%
September 04, 2026 -22.58%
September 03, 2026 -26.37%
September 02, 2026 -27.64%
September 01, 2026 -27.09%
August 31, 2026 -26.81%
August 28, 2026 -33.43%
August 27, 2026 -25.10%
August 26, 2026 -27.02%
August 25, 2026 -21.62%
August 24, 2026 -26.47%
August 21, 2026 -21.21%
August 20, 2026 -30.09%
August 19, 2026 -30.78%
August 18, 2026 -29.00%
August 17, 2026 -35.29%
August 14, 2026 -30.43%
Date Value
August 13, 2026 -34.46%
August 12, 2026 -29.26%
August 11, 2026 -28.17%
August 10, 2026 -29.79%
August 07, 2026 -28.08%
August 06, 2026 -31.98%
August 05, 2026 -63.37%
August 04, 2026 -63.17%
August 03, 2026 -62.59%
July 31, 2026 -62.77%
July 30, 2026 -62.09%
July 29, 2026 -62.09%
July 28, 2026 -63.32%
July 27, 2026 -58.28%
July 24, 2026 -59.53%
July 23, 2026 -60.59%
July 22, 2026 -59.25%
July 21, 2026 -57.17%
July 20, 2026 -56.38%
July 17, 2026 -54.75%
July 16, 2026 -47.91%
July 15, 2026 -38.93%
July 14, 2026 -49.04%
July 13, 2026 -49.89%
July 10, 2026 -47.85%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Co-Diagnostics, Inc. -92.67%
Spectral AI, Inc. -25.79%
Vaxcyte, Inc. 78.37%
Moderna, Inc. 505.3%
Arrowhead Pharmaceuticals, Inc. 111.0%